What is Legal Insider Trading? How do I use this site?
Learn More ›
Login/Signup
Top Companies
Form Screener
Random Insider
Random Company
Sectors
FAQ
Feedback
Blog
Pricing
Fulcrum Therapeutics, Inc. (FULC)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
BUY
20 Jan 2023
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
11,609,704
+19%
1,923,076
$13.00
$24,999,988.00
SELL
13 Jan 2023
Gould Robert J
Interim President & CEO, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
499,864
-1%
6,766
$15.00
$101,490.00
BUY
4 Jan 2023
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,628,259
+1%
180,703
$7.28
$1,314,805.80
BUY
27 Dec 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,505,925
+0%
4,089
$5.99
$24,509.88
BUY
19 Dec 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,501,836
+1%
98,787
$5.90
$582,813.70
BUY
14 Dec 2022
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
9,403,049
+34%
2,403,049
$5.44
$13,073,874.00
SELL
7 Jun 2022
Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630
-12%
71,435
$8.09
$577,894.90
SELL
2 Jun 2022
Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630
-11%
66,622
$8.00
$532,809.94
SELL
7 Apr 2022
Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630
-1%
5,631
$24.02
$135,228.47
SELL
1 Apr 2022
Gould Robert J
Director
Fulcrum Therapeutics, Inc.
(FULC)
506,630
-15%
94,251
$24.16
$2,276,683.80
SELL
10 Aug 2021
Moxham Christopher
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
0
-100%
51,785
$17.60
$911,416.00
SELL
10 Aug 2021
Stuart Bryan
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
0
-100%
60,000
$20.42
$1,225,000.00
BUY
28 Jun 2021
Oltmans Curtis Gale
SVP, General Counsel, Officer
Fulcrum Therapeutics, Inc.
(FULC)
1,088
+100%
1,088
$9.01
$9,802.88
BUY
28 Jun 2021
Morabito Christopher
Chief Medical Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
1,100
+100%
1,100
$9.16
$10,076.00
BUY
28 Jun 2021
Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
2,300
+100%
2,300
$9.00
$20,700.00
BUY
28 Jun 2021
GERAGHTY JAMES A
Director
Fulcrum Therapeutics, Inc.
(FULC)
90,714
+12%
10,000
$9.16
$91,600.00
SELL
15 Mar 2021
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
506,630
-1%
10,000
$12.16
$121,578.33
SELL
22 Feb 2021
Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
15,212
-24%
5,000
$14.72
$73,581.50
SELL
16 Feb 2021
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
518,303
-1%
8,215
$14.27
$117,197.41
SELL
21 Jan 2021
Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
15,212
-30%
6,607
$14.00
$92,498.00
SELL
20 Jan 2021
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
524,845
-1%
10,000
$12.08
$120,826.00
SELL
8 Jul 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
534,845
-0%
2,500
$20.00
$50,000.00
SELL
8 Jul 2020
Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088
-2%
2,951
$20.00
$59,020.00
SELL
1 Jul 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
65,714
-1%
1,071
$18.30
$19,599.30
SELL
30 Jun 2020
Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088
-0%
141
$20.00
$2,820.00
SELL
25 Jun 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
537,345
-0%
2,500
$20.80
$51,992.00
SELL
25 Jun 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785
-2%
1,459
$22.00
$32,098.00
SELL
10 Jun 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785
-0%
401
$22.00
$8,822.00
SELL
9 Jun 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
539,845
-0%
156
$20.00
$3,120.00
SELL
5 Jun 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
540,001
-0%
3,433
$20.17
$69,251.16
SELL
4 Jun 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785
-1%
677
$20.14
$13,632.03
SELL
3 Jun 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
543,434
-0%
2,800
$20.09
$56,250.43
SELL
2 Jun 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785
-0%
383
$20.16
$7,719.59
SELL
1 Jun 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
546,234
-0%
2,802
$20.00
$56,040.00
SELL
28 May 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
549,036
-0%
3,309
$20.04
$66,301.91
SELL
28 May 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785
-1%
800
$20.01
$16,007.00
SELL
28 May 2020
Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088
-1%
2,232
$20.00
$44,640.00
SELL
27 May 2020
Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088
-0%
448
$20.00
$8,960.00
SELL
26 May 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
552,345
-0%
2,500
$20.00
$50,000.00
SELL
26 May 2020
Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088
-0%
412
$20.00
$8,240.00
SELL
12 May 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
66,785
-2%
1,860
$18.00
$33,480.00
SELL
11 May 2020
Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
21,071
-26%
7,500
$16.00
$120,000.00
SELL
2 Mar 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
67,100
-3%
2,143
$17.38
$37,254.78
SELL
24 Feb 2020
Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
30,923
-13%
5,000
$16.83
$84,152.88
SELL
19 Feb 2020
Gould Robert J
See Remarks, Director, Officer
Fulcrum Therapeutics, Inc.
(FULC)
554,845
-0%
2,500
$20.00
$50,000.00
SELL
19 Feb 2020
Wallace Owen B.
Chief Scientific Officer, Officer
Fulcrum Therapeutics, Inc.
(FULC)
127,088
-4%
6,088
$20.00
$121,760.00
SELL
3 Feb 2020
Cadavid Diego
SVP Clinical Development, Officer
Fulcrum Therapeutics, Inc.
(FULC)
68,928
-3%
2,143
$17.33
$37,141.83
SELL
23 Jan 2020
Thomson Peter G.
VP Finance & Accounting, Officer
Fulcrum Therapeutics, Inc.
(FULC)
33,833
-12%
5,000
$17.22
$86,101.95
BUY
22 Jul 2019
Casdin Capital, LLC
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
589,285
+31%
140,000
$15.84
$2,217,495.00
BUY
22 Jul 2019
Third Rock Ventures III, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
5,962,202
+1%
81,250
$16.00
$1,300,000.00
BUY
22 Jul 2019
6 Dimensions Capital, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
559,821
+26%
118,750
$16.00
$1,900,000.00
BUY
22 Jul 2019
Third Rock Ventures IV, L.P.
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
2,343,154
+3%
81,250
$16.00
$1,300,000.00
BUY
22 Jul 2019
Sanofi
10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
558,035
+20%
93,750
$16.00
$1,500,000.00
BUY
22 Jul 2019
LEVIN MARK J
Director, 10% Owner
Fulcrum Therapeutics, Inc.
(FULC)
5,962,202
+1%
81,250
$16.00
$1,300,000.00
Home